Radcliffe Cardiology Launches New Title: JAPSC: Journal of Asian Pacific Society of Cardiology on Behalf of the Asian Pacific Society of Cardiology

April 16, 2021

Radcliffe Cardiology notes: The Asian Pacific Society of Cardiology and Radcliffe Cardiology is pleased to announce the launch of a new open access title, JAPSC: Journal of Asian Pacific Society of Cardiology.

Launching in 2021, JAPSC will be led by Dr. Yeo Khung Keong as Editor-in-Chief and will be the official journal of the Society. This exciting new journal will be a Gold Open Access journal publishing original research, reviews, expert opinion pieces, and case reports within cardiovascular disease and aims to provide a forum for cardiovascular research from across the Asia Pacific region.

Radcliffe Cardiology Launches New Title: JAPSC: Journal of Asian Pacific Society of Cardiology on Behalf of the Asian Pacific Society of Cardiology

On behalf of the APSC, Dr. Yeo Khung Keong commented, “APSC is delighted to work with Radcliffe to launch the Journal of the Asian Pacific Society of Cardiology. We believe that the Asia Pacific has tremendous potential to generate new research and discoveries in the field of cardiovascular medicine and surgery. Given the great burden of cardiovascular disease across the region, the time is right for a cardiovascular journal that truly represents the needs of its people. We are incredibly excited by this opportunity and look forward to the contributions from our friends and colleagues in the Asia Pacific.”

The APSC President, Dr. Jack Tan Wei Chieh, added, “The APSC is excited about the inaugural launch of its dedicated Journal of the Asian Pacific Society of Cardiology, JAPSC. I would like to thank Dr. Wael Almahmeed (UAE) for kick-starting this initiative with a personal donation and the strong collaboration with Radcliffe to bring an Asian perspective to cardiovascular science, research, and education. We are also privileged to have Dr Yeo Khung Keong (Singapore) lead his editorial team members Dr. Junya Ako (Japan), Dr Derek Chew (Australia), and Dr. Kyung Woo Park (Korea) in spearheading JAPSC.”

Radcliffe’s Chief Executive Officer & Co-founder, David Ramsey, commented, “We are delighted to be able to announce the launch of this title in partnership with the Asian Pacific Society of Cardiology, and we believe that this partnership will strengthen our commitment to facilitating the continuous medical education of specialist and general cardiologists and disseminating knowledge of the field to the wider cardiovascular community through open research.”

 

Radcliffe’s Board Chairman, and world-renowned cardiologist, Professor Andrew Coats, himself an Asia-Pacific and EU linked researcher commented, “We at Radcliffe are all delighted to be working in partnership with the Asian Pacific Society of Cardiology, the leading international professional body in cardiovascular medicine in this increasingly important powerhouse region. We are proud of this new journal initiative and know this will strengthen our contribution to the professional medical education of physicians helping care for billions of people.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version